Paper37072467
CBGA ameliorates inflammation and fibrosis in nephropathy.
Suzuki S and 2 others. Sci Rep, 2023. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. CBGA ameliorates inflammation and fibrosis in nephropathy. Papers, record 37072467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37072467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| TRPM Cation Channels | Major topic |
| Ureteral Obstruction | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Cannabinoids | Major topic |
| Humans | |
| Cisplatin | |
| Kidney | |
| Inflammation | |
| Fibrosis | |
| Protein Serine-Threonine Kinases |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AT011162 | NCCIH NIH HHS | United States | R01AT011162 | PubMed and NIH | NIH RePORTER |
| U54 MD007601 | NIMHD NIH HHS | United States | U54MD007601 | PubMed | NIH RePORTER |
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35182322 | Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35182322 | PubMed |
| 2 | 28810912 | Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice. | Cell Commun Signal | 2017 | https://conductscience.org/library/papers/28810912 | PubMed |
| 3 | 36206806 | Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies. | Exp Neurol | 2023 | https://conductscience.org/library/papers/36206806 | PubMed |
| 4 | 21827451 | Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/21827451 | PubMed |
| 5 | 28382507 | Cisplatin nephrotoxicity: a review of the literature. | J Nephrol | 2018 | https://conductscience.org/library/papers/28382507 | PubMed |
| 6 | 30276200 | Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30276200 | PubMed |
| 7 | 25252936 | Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice. | Neurotherapeutics | 2015 | https://conductscience.org/library/papers/25252936 | PubMed |
| 8 | 34140503 | Importance of the renal ion channel TRPM6 in the circadian secretion of renin to raise blood pressure. | Nat Commun | 2021 | https://conductscience.org/library/papers/34140503 | PubMed |
| 9 | 22558406 | The amelioration of renal damage in Skp2-deficient mice canceled by p27 Kip1 deficiency in Skp2-/- p27-/- mice. | PLoS One | 2012 | https://conductscience.org/library/papers/22558406 | PubMed |
| 10 | 30627539 | Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30627539 | PubMed |
| 11 | 16715087 | CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. | Nat Med | 2006 | https://conductscience.org/library/papers/16715087 | PubMed |
| 12 | 10212589 | Cisplatin and hypomagnesemia. | Cancer Treat Rev | 1999 | https://conductscience.org/library/papers/10212589 | PubMed |
| 13 | 35707521 | Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice. | Front Cell Neurosci | 2022 | https://conductscience.org/library/papers/35707521 | PubMed |
| 14 | 17620370 | Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice. | Am J Pathol | 2007 | https://conductscience.org/library/papers/17620370 | PubMed |
| 15 | 28720466 | Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. | Prog Neuropsychopharmacol Biol Psychiatry | 2017 | https://conductscience.org/library/papers/28720466 | PubMed |
| 16 | 375794 | Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. | Ann Intern Med | 1979 | https://conductscience.org/library/papers/375794 | PubMed |
| 17 | 22242975 | Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22242975 | PubMed |
| 18 | 22017545 | Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy. | Genes Cells | 2011 | https://conductscience.org/library/papers/22017545 | PubMed |
| 19 | 28724610 | Developing better mouse models to study cisplatin-induced kidney injury. | Am J Physiol Renal Physiol | 2017 | https://conductscience.org/library/papers/28724610 | PubMed |
| 20 | 13680535 | Cisplatin nephrotoxicity. | Semin Nephrol | 2003 | https://conductscience.org/library/papers/13680535 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42572649 | Emerging roles of cannabinoid pathways in renal injury and repair. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42572649 | PubMed |
| 42121212 | Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration. | J Cannabis Res | 2026 | https://conductscience.org/library/papers/42121212 | PubMed |
| 41822224 | Physiological effect and pharmacokinetic evaluation of combined oral administration of cannabidiolic acid and cannabigerolic acid in dogs. | Front Vet Sci | 2026 | https://conductscience.org/library/papers/41822224 | PubMed |
| 41545891 | Therapeutic potential of acidic cannabinoids: an update. | J Cannabis Res | 2026 | https://conductscience.org/library/papers/41545891 | PubMed |
| 41272047 | Cannabidiol inhibits TGF-β1-induced epithelial-mesenchymal transition in human conjunctival epithelial cells by interrupting TGF-β/Smad signaling. | Sci Rep | 2025 | https://conductscience.org/library/papers/41272047 | PubMed |
| 41226279 | The Action of Cannabidiol on Doxycycline Cytotoxicity in Human Cells-In Vitro Study. | Molecules | 2025 | https://conductscience.org/library/papers/41226279 | PubMed |
| 41118703 | Physiological functions and pharmacological targeting of transient receptor potential channels. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/41118703 | PubMed |
| 40289808 | The critical role of ion channels in kidney disease: perspective from AKI and CKD. | Ren Fail | 2025 | https://conductscience.org/library/papers/40289808 | PubMed |
| 39851511 | Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway. | Cells | 2025 | https://conductscience.org/library/papers/39851511 | PubMed |
| 39819647 | Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis. | J Cannabis Res | 2025 | https://conductscience.org/library/papers/39819647 | PubMed |
| 39769305 | Protective Action of Cannabidiol on Tiamulin Toxicity in Humans-In Vitro Study. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769305 | PubMed |
| 38675145 | CBD and THC in Special Populations: Pharmacokinetics and Drug-Drug Interactions. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38675145 | PubMed |
| 38162115 | Cannabigerolic Acid (CBGA) Inhibits the TRPM7 Ion Channel Through its Kinase Domain. | Function (Oxf) | 2024 | https://conductscience.org/library/papers/38162115 | PubMed |
| 37853091 | TRPM channels in health and disease. | Nat Rev Nephrol | 2024 | https://conductscience.org/library/papers/37853091 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| TRPM7 | 54822 | PubTator's text mining | https://conductscience.org/library/genes/54822 | NCBI Gene |
| TUBA1B | 10376 | PubTator's text mining | https://conductscience.org/library/genes/10376 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37072467
GET https://conductscience.org/api/papers/v1/37072467/references?page=2